Sanders launches investigation into ‘unacceptable’ diabetes, weight loss drug prices
by TheHill
TheHill— Sen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, on Wednesday launched an investigation into the “outrageously high prices” of Novo Nordisk’s respective diabetes and weight loss drugs, Ozempic and Wegovy. On Wednesday, Sanders penned a letter to Novo Nordisk’s chief executive officer, Lars Fruergaard Jørgensen, notifying him of
Global News—Wegovy set to launch in Canada. What to know about the weight-loss drug. Wegovy can also be prescribed to patients who are significantly overweight and have at least one related medical condition such as high blood pressure and Type 2 diabetes.
Fast Company—How weight-loss drugs are changing the diet industry. Ever since college, Brad Jobling struggled with his weight, fluctuating between a low of 155 pounds when he was in his thirties to as high as 220. He spent a decade tracking calories on WeightWatchers, but the pounds he dropped always crept back onto his 5-foot-5-inch frame. A little over a year ago, the 58-year-old Manhattan resident went on a new weight loss drug called Wegovy. He’s lost 30 pounds, and has started eating healthier food and exercising—the habits behind many commercial diet...
Gothamist—Extra Extra: Don't buy weight loss drugs from TikTok. Because it's best to get your medication from a doctor, here are your afternoon links: a push for dog poop bags, a chance to live in a decked out Skittles apartment, why Cher dates young men, and more from around the city and internet. [ more › ]